Molecule intelOpportunity: ModerateEssentialCrowded market

Terbinafine

225 brands · 100 companies · product forms

ATC: D01AE15, D01BA02 41 DRAP alerts

Opportunity snapshot

Launch attractiveness
49
Market saturation
100
Price room
100
Regulatory risk
90
225
brands
100
companies
Rs 319.33
median price
197
price points
23.63x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 3%

Price room

Across observed sources and strengths
CheapestRs 147.21
MedianRs 319.33
Most expensiveRs 3,478.75
Spread23.63×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 23.63x across 197 trusted points (Rs 147.21-3478.75). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Terbinafine — each links to its own medicine page.

Regulatory alerts

Recall exposureSafety exposurelatest 2026-04-14
RECALL ALERT – BATCHES OF ‘TABLET FAMILA 28F’ DECLARED SUBSTANDARD BY CENTRAL DRUGS LABORA
02. Recall Alert (Class-II) – Drug Products tested by DTL Punjab
23. Recall Alert – Class II – Drug Products – Provincial reports
Recall Alert: Recall of Nabaxo 10mg Film Coated Tablet Manufactured By M/s. Wenovo Pharmac
Recall Alert – Adulterated Tablet Virtec 10 mg (Batch # FK-24-007)
RAPID ALERT – SPURIOUS / FALSIFIED (TABLET FEMARA 2.5 mg)

Why this score

Launch attractiveness

40% supply-gap(45) + 25% price-variation(100) + 20% low-competition(0) + 15% supply-disruption(40), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

100 canonical companies and 225 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 23.63x across 197 trusted points (Rs 147.21-3478.75). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

41 DRAP alert(s), latest 2026-04-14 incl. recall/safety.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.